VanEck Associates’s Gildan GIL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$12K Buy
224
+85
+61% +$5.5K ﹤0.01% 1378
2025
Q4
$9K Buy
139
+49
+54% +$2.91K ﹤0.01% 1386
2025
Q3
$5K Buy
+90
New +$4.82K ﹤0.01% 1412
2015
Q3
Sell
-198
Closed -$7K 812
2015
Q2
$7K Sell
198
-686
-78% -$22K ﹤0.01% 811
2015
Q1
$26K Buy
884
+306
+53% +$8.94K ﹤0.01% 745
2014
Q4
$16K Buy
578
+344
+147% +$9.79K ﹤0.01% 736
2014
Q3
$6K Buy
+234
New +$6.76K ﹤0.01% 697

Other funds holding GIL

VanEck Associates's GIL Position: Q1 2026 in Review

VanEck Associates increased its Gildan (GIL) stake by 61% in Q1 2026, buying an estimated $5.5K and bringing the position to 224 shares worth $12K. The position accounts for ﹤0.01% of the portfolio, ranked #1378.

VanEck Associates first reported a position in GIL in Q3 2014 and has held it in 7 quarters since. The position peaked at $26K in Q1 2015. 484 funds tracked by Wall St. Rank hold GIL as of Q1 2026.

  • VanEck Associates held 224 shares of Gildan worth $12K as of Q1 2026.
  • VanEck Associates bought 85 Gildan shares in Q1 2026, an estimated $5.5K.
  • Gildan made up ﹤0.01% of VanEck Associates's portfolio in Q1 2026, its #1378 holding.
  • VanEck Associates first reported a position in Gildan in Q3 2014 and has held it in 7 quarters since.
  • VanEck Associates's Gildan position peaked at $26K in Q1 2015.
  • 484 funds tracked by Wall St. Rank held Gildan as of Q1 2026.

Based on VanEck Associates's 13F filing for Q1 2026, filed 15 May 2026.